S&P 500   3,852.36
DOW   32,920.46
QQQ   303.59
Mullen Automotive Stock, The Tide Has Turned
Apple, Amazon, and Walmart are Investing in Solar Energy (Ad)
Energizer Holdings Inc; Losing Power Or Electrifying Time To Buy?
How to Find Penny Stocks to Invest and Trade
The #1 Energy Stock to Buy (Ad)
What Tyson Foods Q1 Means For Staples Stocks
ONSemi Is Marching Higher On Great Results
The #1 Energy Stock to Buy (Ad)
Can Cummins Power To A New High? 
Is BigBear.ai Stock a Diamond in the Rough?
S&P 500   3,852.36
DOW   32,920.46
QQQ   303.59
Mullen Automotive Stock, The Tide Has Turned
Apple, Amazon, and Walmart are Investing in Solar Energy (Ad)
Energizer Holdings Inc; Losing Power Or Electrifying Time To Buy?
How to Find Penny Stocks to Invest and Trade
The #1 Energy Stock to Buy (Ad)
What Tyson Foods Q1 Means For Staples Stocks
ONSemi Is Marching Higher On Great Results
The #1 Energy Stock to Buy (Ad)
Can Cummins Power To A New High? 
Is BigBear.ai Stock a Diamond in the Rough?
S&P 500   3,852.36
DOW   32,920.46
QQQ   303.59
Mullen Automotive Stock, The Tide Has Turned
Apple, Amazon, and Walmart are Investing in Solar Energy (Ad)
Energizer Holdings Inc; Losing Power Or Electrifying Time To Buy?
How to Find Penny Stocks to Invest and Trade
The #1 Energy Stock to Buy (Ad)
What Tyson Foods Q1 Means For Staples Stocks
ONSemi Is Marching Higher On Great Results
The #1 Energy Stock to Buy (Ad)
Can Cummins Power To A New High? 
Is BigBear.ai Stock a Diamond in the Rough?
S&P 500   3,852.36
DOW   32,920.46
QQQ   303.59
Mullen Automotive Stock, The Tide Has Turned
Apple, Amazon, and Walmart are Investing in Solar Energy (Ad)
Energizer Holdings Inc; Losing Power Or Electrifying Time To Buy?
How to Find Penny Stocks to Invest and Trade
The #1 Energy Stock to Buy (Ad)
What Tyson Foods Q1 Means For Staples Stocks
ONSemi Is Marching Higher On Great Results
The #1 Energy Stock to Buy (Ad)
Can Cummins Power To A New High? 
Is BigBear.ai Stock a Diamond in the Rough?
NASDAQ:TMCI

Treace Medical Concepts - TMCI Stock Forecast, Price & News

$23.79
-0.68 (-2.78%)
(As of 02/6/2023 12:00 AM ET)
Add
Compare
Today's Range
$23.69
$24.38
50-Day Range
$22.12
$26.22
52-Week Range
$12.48
$26.50
Volume
98,483 shs
Average Volume
311,212 shs
Market Capitalization
$1.32 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$28.00

Treace Medical Concepts MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
17.7% Upside
$28.00 Price Target
Short Interest
Bearish
5.42% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.01mentions of Treace Medical Concepts in the last 14 days
Based on 8 Articles This Week
Insider Trading
Selling Shares
$13.09 M Sold Last Quarter
Proj. Earnings Growth
N/A

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.65 out of 5 stars

Medical Sector

849th out of 1,027 stocks

Surgical & Medical Instruments Industry

92nd out of 105 stocks

TMCI stock logo

About Treace Medical Concepts (NASDAQ:TMCI) Stock

Treace Medical Concepts, Inc., an orthopedic medical device company, engages in the design, manufacture, and marketing of medical devices for foot and ankle surgeons in the United States. It offers Lapiplasty procedure that allows podiatric surgeons to treat all three dimensions of the bunion, providing patients with a cosmetic and medical improvement. The company also provides Lapiplasty Mini-Incision precision system. In addition, it offers products to address ancillary surgical procedures, including akin osteotomies, weil osteotomies, intercuneiform stabilization, lesser tarsometatarsal joint fusions, and autograft bone harvesting, as well as for MTP fusion. Treace Medical Concepts, Inc. was founded in 2013 and is headquartered in Ponte Vedra Beach, Florida.

Receive TMCI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Treace Medical Concepts and its competitors with MarketBeat's FREE daily newsletter.

TMCI Stock News Headlines

The #1 Energy Stock to Buy
The next major energy revolution is unfolding right now. And it could hand early investors as much as 46,700% gains…
The #1 Energy Stock to Buy
The next major energy revolution is unfolding right now. And it could hand early investors as much as 46,700% gains…
Treace Investor Alert
See More Headlines
Receive TMCI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Treace Medical Concepts and its competitors with MarketBeat's FREE daily newsletter.

TMCI Company Calendar

Last Earnings
11/04/2021
Today
2/07/2023
Next Earnings (Estimated)
3/02/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:TMCI
Fax
N/A
Employees
248
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$28.00
High Stock Price Forecast
$29.00
Low Stock Price Forecast
$27.00
Forecasted Upside/Downside
+17.7%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
3 Analysts

Profitability

Net Income
$-20,550,000.00
Pretax Margin
-35.87%

Debt

Sales & Book Value

Annual Sales
$94.42 million
Book Value
$1.75 per share

Miscellaneous

Free Float
32,252,000
Market Cap
$1.32 billion
Optionable
Not Optionable
Beta
-0.13

Key Executives

  • Mr. John T. TreaceMr. John T. Treace (Age 51)
    CEO, Founder & Director
    Comp: $688.14k
  • Mr. Mark L. Hair CPA (Age 52)
    Chief Financial Officer
    Comp: $688.22k
  • Mr. Aaron Berutti (Age 44)
    Sr. VP of Sales
    Comp: $323.62k
  • Mr. Terry W. Lubben (Age 58)
    Sr. VP of Operations
  • Mr. Scot Elder (Age 48)
    Chief Legal & Compliance Officer and Corp. Sec.
  • Dr. Sean F. Scanlan Ph.D. (Age 41)
    Sr. VP of Marketing
  • Mr. Daniel E. Owens (Age 51)
    Chief HR Officer
  • Mr. Jaime A. Frias (Age 61)
    Chief Bus. Devel. Officer
  • Ms. Shana Zink
    Sr. VP of Clinical Affairs, Medical Education & Reimbursement
  • Ms. Rachel Osbeck
    Sr. VP of Quality Assurance & Regulatory Affairs













TMCI Stock - Frequently Asked Questions

Should I buy or sell Treace Medical Concepts stock right now?

3 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Treace Medical Concepts in the last year. There are currently 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" TMCI shares.
View TMCI analyst ratings
or view top-rated stocks.

What is Treace Medical Concepts' stock price forecast for 2023?

3 Wall Street research analysts have issued 1-year target prices for Treace Medical Concepts' shares. Their TMCI share price forecasts range from $27.00 to $29.00. On average, they expect the company's stock price to reach $28.00 in the next twelve months. This suggests a possible upside of 17.7% from the stock's current price.
View analysts price targets for TMCI
or view top-rated stocks among Wall Street analysts.

How have TMCI shares performed in 2023?

Treace Medical Concepts' stock was trading at $22.99 at the start of the year. Since then, TMCI stock has increased by 3.5% and is now trading at $23.79.
View the best growth stocks for 2023 here
.

When is Treace Medical Concepts' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, March 2nd 2023.
View our TMCI earnings forecast
.

How were Treace Medical Concepts' earnings last quarter?

Treace Medical Concepts, Inc. (NASDAQ:TMCI) issued its quarterly earnings results on Thursday, November, 4th. The company reported ($0.12) EPS for the quarter, meeting analysts' consensus estimates of ($0.12). The business had revenue of $21.62 million for the quarter, compared to the consensus estimate of $21.06 million. Treace Medical Concepts had a negative net margin of 35.87% and a negative trailing twelve-month return on equity of 51.67%.

What guidance has Treace Medical Concepts issued on next quarter's earnings?

Treace Medical Concepts updated its FY 2022 earnings guidance on Friday, January, 27th. The company provided EPS guidance of for the period. The company issued revenue guidance of $141.20 million-$141.70 million, compared to the consensus revenue estimate of $137.01 million.

When did Treace Medical Concepts IPO?

(TMCI) raised $150 million in an initial public offering on Friday, April 23rd 2021. The company issued 9,400,000 shares at $15.00-$17.00 per share. J.P. Morgan and Morgan Stanley served as the underwriters for the IPO and SVB Leerink and Stifel were co-managers.

What is Treace Medical Concepts' stock symbol?

Treace Medical Concepts trades on the NASDAQ under the ticker symbol "TMCI."

Who are Treace Medical Concepts' major shareholders?

Treace Medical Concepts' stock is owned by a variety of institutional and retail investors. Top institutional investors include Emerald Advisers LLC (2.14%), Emerald Mutual Fund Advisers Trust (1.70%), Allspring Global Investments Holdings LLC (0.86%), Calamos Advisors LLC (0.29%), Essex Investment Management Co. LLC (0.25%) and Lisanti Capital Growth LLC (0.11%). Insiders that own company stock include Aaron Berutti, Daniel E Owens, F Barry Bays, Jaime A Frias, James T Treace, John R Treace, John T Treace, Mark Hair, Richard W Mott, Scot Michael Elder, Sean F Scanlan, Terry W Lubben and Thomas E Timbie.
View institutional ownership trends
.

How do I buy shares of Treace Medical Concepts?

Shares of TMCI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Treace Medical Concepts' stock price today?

One share of TMCI stock can currently be purchased for approximately $23.79.

How much money does Treace Medical Concepts make?

Treace Medical Concepts (NASDAQ:TMCI) has a market capitalization of $1.32 billion and generates $94.42 million in revenue each year. The company earns $-20,550,000.00 in net income (profit) each year or ($0.81) on an earnings per share basis.

How many employees does Treace Medical Concepts have?

The company employs 248 workers across the globe.

How can I contact Treace Medical Concepts?

Treace Medical Concepts' mailing address is 203 FORT WADE RD. SUITE 150, PONTE VEDRA FL, 32081. The official website for the company is www.treace.com. The company can be reached via phone at 904-373-5940 or via email at ir@treace.net.

This page (NASDAQ:TMCI) was last updated on 2/7/2023 by MarketBeat.com Staff